Onward Medical N.V.
ONWRF
$5.70
-$0.42-6.86%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 500.89% | 452.26% | 482.74% | 490.53% | -77.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 500.89% | 452.26% | 482.74% | 490.53% | -77.85% |
| Cost of Revenue | -4.80% | -12.48% | 5.78% | 7.90% | -23.07% |
| Gross Profit | 21.04% | 27.41% | 21.25% | 19.67% | 16.44% |
| SG&A Expenses | 32.75% | 22.05% | 21.56% | 24.00% | 6.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.69% | 8.19% | 7.16% | 9.31% | -4.89% |
| Operating Income | -12.33% | -3.27% | 4.48% | 2.55% | 1.28% |
| Income Before Tax | -19.23% | -9.61% | -1.12% | -3.15% | 4.55% |
| Income Tax Expenses | 159.67% | 154.87% | 343.71% | 353.41% | -798.37% |
| Earnings from Continuing Operations | -22.35% | -12.48% | -2.38% | -4.44% | 6.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.35% | -12.48% | -2.38% | -4.44% | 6.40% |
| EBIT | -12.33% | -3.27% | 4.48% | 2.55% | 1.28% |
| EBITDA | -12.30% | -3.24% | 4.82% | 3.03% | 1.85% |
| EPS Basic | 5.11% | 12.76% | 43.32% | 42.19% | 18.55% |
| Normalized Basic EPS | 7.54% | 14.95% | 44.05% | 42.93% | 16.94% |
| EPS Diluted | 5.61% | 13.24% | 43.45% | 42.32% | 18.12% |
| Normalized Diluted EPS | 7.54% | 14.95% | 44.05% | 42.93% | 16.94% |
| Average Basic Shares Outstanding | 28.91% | 28.91% | 80.66% | 80.66% | 14.93% |
| Average Diluted Shares Outstanding | 28.91% | 28.91% | 80.66% | 80.66% | 14.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |